No CrossRef data available.
Article contents
The differential diagnosis of Parkinson's disease
Published online by Cambridge University Press: 17 November 2008
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Clinical geriatrics
- Information
- Copyright
- Copyright © Cambridge University Press 1995
References
1 Parkinson's disease: one illness or many syndromes? [Editorial]. Lancet 1992; 339: 1263–64.CrossRefGoogle Scholar
2Geddes, JF, Hughes, AJ, Lees, AJ, Daniel, SE. Pathological overlap in cases of parkinsonism associated with neurofibrillary tangles: a study of recent cases of postencephalitic parkinsonism and comparison with progressive supranuclear palsy and Guamanian parkinsonism-dementia complex. Brain 1993; 116: 281–302.CrossRefGoogle ScholarPubMed
3Brooks, DJ. PET studies on the early and differential diagnosis of Parkinson's disease. Neurology 1993; 43 (suppl 6): S6–S16.Google ScholarPubMed
4Ward, CD. Parkinson's disease and related conditions: clinical features, epidemiology and differential diagnosis. In: Swash, M, Oxbury, J eds. Clinical neurology. Edinburgh: Churchill Livingstone, 1991: 1396–425.Google Scholar
5Hughes, AJ, Ben-Shlomo, Y, Daniel, SE, Lees, AJ. What features improve the accuracy of the clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992; 42: 1142–46.CrossRefGoogle ScholarPubMed
6Hardie, RJ. Parkinson's disease: treatment. In: Swash, M, Oxbury, J eds. Clinical neurology. Edinburgh: Churchill Livingstone, 1991: 1425–45.Google Scholar
7Ward, CD, Gibb, WR. Research diagnostic criteria for Parkinson's disease. Adv Neural 1990; 53: 245–49.Google ScholarPubMed
8Calne, DB, Snow, BJ, Lee, C. Criteria for diagnosing Parkinson's disease: clinical and theoretical implications. Neurology 1992; 32: S125–S127.Google Scholar
9Hardie, RJ, Lees, AJ. Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa. J Neurol Neurosurg Psychiatry 1988; 51: 850–54.CrossRefGoogle ScholarPubMed
10Robbins, TW, James, M, Owen, AM et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neural Neurosurg Psychiatry 1994; 57: 79–88.CrossRefGoogle ScholarPubMed
11Henn, V. Pathophysiology of rapid eye movements in the horizontal, vertical and torsional directions. In: Buttner, U, Brandt, T eds. Ocular motor disorders of the brain stem. London: Baillière, 1992: 373–91.Google Scholar
12Pierrot-Deseilligny, C, Gaymard, B. Smooth pursuit disorders. In: Buttner, U, Brandt, T eds. Ocular motor disorders of the brain stem. London: Baillière, 1992: 435–54.Google Scholar
13Maher, ER, Lees, AJ. The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1986; 36: 1005–1008.CrossRefGoogle ScholarPubMed
14Lepore, F, Duvoisin, RC. ‘Apraxia’ of eyelid opening. An involuntary levator inhibition. Neurology 1985; 35: 423–27.CrossRefGoogle ScholarPubMed
15Quinn, NP, Marsden, CD. The motor disorder of multiple system atrophy. J Neural Neurosurg Psychiatry 1993; 56: 1239–42.CrossRefGoogle ScholarPubMed
16Hardie, RJ, Pullon, HWH, Harding, AE et al. Neuroacanthocytosis: a clinical, haematological and neuropathological study of 19 cases. Brain 1991; 114: 13–49.Google Scholar
17Bain, P. A combined clinical and neurophysiological approach to the study of patients with tremor. J Neural Neurosurg Psychiatry 1993; 56: 839–44.CrossRefGoogle Scholar
18Brooks, DJ, Playford, ED, Ibanez, V et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology 1992; 42: 1554–60.CrossRefGoogle ScholarPubMed
19Muhiddin, KA, Hardie, RJ, Pearce, VR, Kirby, BJ. Corticobasal degeneration: a report of three cases. J R Soc Med 1994; 87: 359–60.CrossRefGoogle ScholarPubMed
20Fleminger, S. Control of simultaneous movements distinguishes depressive motor retardation from Parkinson's disease and neuroleptic parkinsonism. Brain 1992; 115: 1459–80.CrossRefGoogle ScholarPubMed
21Rogers, D, Lees, AJ, Smith, E, Trimble, M, Stern, GM. Bradyphrenia in Parkinson's disease and psychomotor retardation in depressive illness: an experimental study. Brain 1987; 110: 761–76.CrossRefGoogle ScholarPubMed
23Thompson, PD, Marsden, CD. Gait disorder of subcortical arteriosclerotic encephalopathy: Binswanger's disease. Mov Disord 1987; 2: 1–8.CrossRefGoogle ScholarPubMed
24Hoehn, MM, Yahr, MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17: 427–42.CrossRefGoogle ScholarPubMed
25Hardie, RJ, Lees, AJ, Stern, GM. On-off fluctuations in Parkinson's disease: a clinical and neuropharmacological study. Brain 1984; 107: 487–506.CrossRefGoogle ScholarPubMed
26Hughes, AJ, Lees, AJ, Stern, GM. Challenge tests to predict the dopaminergic response in untreated Parkinson's disease. Neurology 1991; 41: 1723–25.CrossRefGoogle ScholarPubMed
27Gasser, T, Schwarz, J, Arnold, G, Trenkwalder, C, Oertel, WH. Apomorphine test for dopaminergic responsiveness in patients with previously untreated Parkinson's disease. Arch Neural 1992; 42: 1131–34.CrossRefGoogle Scholar
28Hughes, AJ, Daniel, SE, Blankson, S, Lees, AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 1993; 50: 140–48.CrossRefGoogle ScholarPubMed